Archives
-
Bufuralol Hydrochloride in Organoid PK Assays
2026-08-22
Bufuralol hydrochloride can connect β-adrenergic pharmacology with exposure-aware intestinal models. This article shows how hiPSC-derived organoids can separate receptor effects from absorption, metabolism, and transporter behavior in cardiovascular pharmacology research.
-
Broussonetia papyrifera and Alzheimer’s Pathogenesis
2026-08-22
A 2026 Journal of Ethnopharmacology study identifies the ethyl acetate fraction of Broussonetia papyrifera fruit as a multi-target neuroprotective preparation that reduces amyloid-beta proteotoxicity while restoring antioxidant and mitochondrial defenses. By combining C. elegans, cellular, transcriptomic, and activity-guided fractionation approaches, the work provides a mechanistic framework for evaluating a traditional botanical intervention without equating model-level efficacy with clinical benefit.
-
MTT Assay Reagent: Mechanism and Workflow
2026-08-21
MTT, or 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide, is a colorimetric reagent for estimating cellular metabolic activity in cultured cells. Its purple formazan signal is useful for proliferation and cytotoxicity studies, but it reports reducing activity rather than cell number alone.
-
FITC-Concanavalin A (ConA) Conjugate Guide
2026-08-20
FITC-Concanavalin A (ConA) Conjugate provides a direct fluorescent method for visualizing accessible α-D-glucose and α-D-mannose moieties on glycoproteins and glycolipids. It is intended for cell surface carbohydrate detection, immunofluorescence staining, tissue labeling, and flow cytometry, not for general protein staining, non-carbohydrate targets, or use beyond the stated storage and stability conditions.
-
From Lipid Rafts to Low-Abundance Signals
2026-08-20
A translational perspective on how CAF-derived fatty acids reshape oral cancer signaling—and why rigorous western blot chemiluminescent detection is essential for validating low-abundance pathway proteins.
-
Psora 4: Decoding Kv1.3 Assay Context
2026-08-19
Psora 4 is a potent Kv1.3 blocker for dissecting membrane-potential control of T cell calcium signaling. This article explains how KCNE4-dependent channel architecture changes pharmacological interpretation and assay design beyond simple potency measurements.
-
Ziprasidone Augmentation in Anxious Depression
2026-08-19
This post-hoc moderator analysis examined whether anxious depression altered the antidepressant or anxiolytic response to ziprasidone augmentation of escitalopram. The analysis found no meaningful moderation of depressive symptom improvement, while the anxiety findings favored patients without anxious depression but did not establish a clinically significant benefit in the anxious subgroup.
-
TMRE, Sodium Stress, and Mitochondrial Fate
2026-08-18
A translational framework for using TMRE fluorescence to connect sodium-driven mitochondrial energy failure with cell fate, while defining controls, interpretation limits, and assay strategies for apoptosis, mitochondrial dysfunction, and disease modeling.
-
AP20187 for Causal Control of Tumor Stroma
2026-08-18
AP20187 is a chemical inducer of dimerization for building temporally controlled signaling experiments. This guide connects its conditional activation logic with senescent CAF–NK cell biology, emphasizing causal assay design rather than routine product handling.
-
TMRE Mitochondrial Membrane Potential Assay
2026-08-17
The TMRE mitochondrial membrane potential assay kit provides a functional window into mitochondrial depolarization during sodium-driven energy failure and apoptosis. This guide connects the K2233 workflow to recent mechanistic findings while explaining controls, interpretation limits, and experimental design choices.
-
Cy5-Labeled mRNA in Macrophage Assays
2026-08-17
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) separates mRNA uptake from productive translation in macrophage delivery studies. This article presents a dual-channel assay strategy grounded in nanoparticle targeting evidence and practical fluorescence controls.
-
X-Gal Workflows for Molecular Cloning
2026-08-16
X-Gal converts β-galactosidase activity into a visible blue signal, making clone selection fast while supporting reporter and construct-validation workflows. This guide connects reliable blue-white colony screening with practical assay design inspired by recent olfactory receptor research.
-
Medroxyprogesterone Acetate: A Translational Lens
2026-08-15
Medroxyprogesterone acetate is more than a conventional progestin control. Its progesterone receptor activity, glucocorticoid receptor engagement, and tissue-specific effects create a useful framework for connecting reproductive, renal, and neurobiological research. This article interprets MPA alongside new evidence on vitamin D/VDR-driven endometrial decidualization, then translates the biology into practical study-design guidance, validation priorities, and a strategic roadmap for translational researchers.
-
Lin28B/Let-7/PBK Targeting in TNBC
2026-08-14
This study identifies ponicidin as a candidate inhibitor of Lin28B and connects its activity to restoration of Let-7 signaling and suppression of PBK and other oncogenic proteins in triple-negative breast cancer. By combining computational screening, biophysical binding analysis, cellular assays, and an orthotopic mouse model, the work provides an initial framework for Lin28B-directed drug discovery while highlighting important validation gaps.
-
SB525334: Interpreting TGF-β1 Pathway Causality
2026-08-14
SB525334 is a selective TGF-beta1 receptor inhibitor for dissecting ALK5-driven Smad signaling. This article uses diabetic wound-healing evidence to show how pathway inhibition can distinguish regenerative signaling from maladaptive fibrosis and improve assay interpretation.